nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
|
Frogne, Thomas |
|
2008 |
114 |
2 |
p. 263-275 |
artikel |
2 |
Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women
|
Zhang, Lina |
|
2008 |
114 |
2 |
p. 327-338 |
artikel |
3 |
Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population
|
Kohaar, Indu |
|
2008 |
114 |
2 |
p. 347-355 |
artikel |
4 |
Axillary recurrence after negative sentinel lymph node biopsy
|
Kim, Hee Jeong |
|
2008 |
114 |
2 |
p. 301-305 |
artikel |
5 |
Breast cancer characteristics at diagnosis and survival among Arab–American women compared to European– and African–American women
|
Hensley Alford, Sharon |
|
2008 |
114 |
2 |
p. 339-346 |
artikel |
6 |
Changes in quality of life among breast cancer patients three years post-diagnosis
|
Lu, Wei |
|
2008 |
114 |
2 |
p. 357-369 |
artikel |
7 |
Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells
|
Zhang, Hua |
|
2008 |
114 |
2 |
p. 277-285 |
artikel |
8 |
Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence
|
Marques, Ana Rita |
|
2008 |
114 |
2 |
p. 223-232 |
artikel |
9 |
Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles
|
Yuvaraj, Srinivasan |
|
2008 |
114 |
2 |
p. 377-384 |
artikel |
10 |
Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation
|
Stigliano, Ivan |
|
2008 |
114 |
2 |
p. 251-262 |
artikel |
11 |
HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis
|
Tao, Weiyang |
|
2008 |
114 |
2 |
p. 371-376 |
artikel |
12 |
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
|
Perez, Edith A. |
|
2008 |
114 |
2 |
p. 195-201 |
artikel |
13 |
Molecular profiles of progesterone receptor loss in human breast tumors
|
Creighton, Chad J. |
|
2008 |
114 |
2 |
p. 287-299 |
artikel |
14 |
Poor usage of HUGO standard gene nomenclature in breast cancer studies
|
Lacroix, Marc |
|
2008 |
114 |
2 |
p. 385-386 |
artikel |
15 |
Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression
|
Nieves-Alicea, René |
|
2008 |
114 |
2 |
p. 203-209 |
artikel |
16 |
Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence
|
Carraway, Hetty E. |
|
2008 |
114 |
2 |
p. 315-325 |
artikel |
17 |
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region
|
Richards, Gregory M. |
|
2008 |
114 |
2 |
p. 307-313 |
artikel |
18 |
RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation
|
Stigliano, Ivan |
|
|
114 |
2 |
p. 251-262 |
artikel |
19 |
Src inhibitors in early breast cancer: a methodology, feasibility and variability study
|
Jones, R. J. |
|
2008 |
114 |
2 |
p. 211-221 |
artikel |
20 |
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology
|
Rakha, Emad A. |
|
2008 |
114 |
2 |
p. 243-250 |
artikel |
21 |
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
|
Hadad, Sirwan M. |
|
2008 |
114 |
2 |
p. 391 |
artikel |
22 |
Transcriptional profiles of progestogen effects in the postmenopausal breast
|
Wood, Charles E. |
|
2008 |
114 |
2 |
p. 233-242 |
artikel |
23 |
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
|
Stambolic, Vuk |
|
2008 |
114 |
2 |
p. 387-389 |
artikel |